Arnaud Bayle, Medical oncologist and health economist working at Gustave Roussy Cancer Center, shared a post on LinkedIn:
“ESMO tools for HTA: The example of ESCAT in Italy
Excellent presentation by Dario Trapani at ESMO25 on how ESMO tools like ESCAT can guide clinical value and support Health Technology Assessment (HTA) across Europe.
Italy has already integrated ESCAT-based testing into national reimbursement — a major step forward.
Yet misalignments between drug approvals, test reimbursement, and eligibility definitions still limit timely and equitable access to innovation.
Harmonised and coordinated policies will be key to ensuring patients receive the right treatment at the right time.”
Follow the latest ESMO 2025 news on OncoDaily.
